v. 13.2.2.0 software (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
v. 13.2.2.0 software
V. 13.2.2.0 Software, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v%2E+13%2E2%2E2%2E0+software/v++13+2+2+0+software/pm26891048-68-5-8
Average 90 stars, based on 1 article reviews
V. 13.2.2.0 Software, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/v%2E+13%2E2%2E2%2E0+software/v++13+2+2+0+software/pm26891048-68-5-8
Average 90 stars, based on 1 article reviews
v. 13.2.2.0 software - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Tumor Heterogeneity Assessed by 18F-FDG PET/CT Is Not Significantly Associated with Nodal Metastasis in Breast Cancer Patients. Article Snippet: Among female patients, breast cancer is the most frequently diagnosed cancer and it is the second most common cause of cancer death [1].. Previous studies evaluated the association between [18F] fluorodeoxyglucose (18F-FDG) positron emission tomography/ computed tomography (PET/CT) and breast cancer.. PET/CT has a benefit for initial staging, detecting nodal and distant metastases and making prognoses for breast cancer [2]. |